Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Teva Pharma Wants to Enter China Market via Partnerships

publication date: Aug 16, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Teva Pharma, the global generic drugmaker headquartered in Israel, is aiming at the drug markets of China and Brazil as the next targets for its global expansion. To gain a foothold is these emerging markets, the company will forge strategic alliances, said Jeremy Levin, the company’s CEO, at an investment conference. In the past, Teva made blockbuster acquisitions, but it now emphasizes smaller, more cooperative ventures. More details....

Stock Symbol: (NYSE: TEVA)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...